InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001415889-23-004077 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 TDOC Geshuri Arnnon CHRO M - OptEx — +4,716 77.9K +6% —
D 2023-03-03 2023-03-02 TDOC Geshuri Arnnon CHRO S - Sale+OE $25.36 -1,665 76.3K -2% -$42.2K
D 2023-03-03 2023-03-01 TDOC Geshuri Arnnon CHRO M - OptEx $0.00 -4,716 9,433 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 M A 4,716 — 77,943 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2023-03-02 S D 1,665 $25.36 76,278 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2023-03-01 M D 4,716 $0.00 9,433 D — · — to — 4,716 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.